Summary
- Splice variants
- Transcript comparison
- Gene alleles
Sequence
- Secondary Structure
Comparative Genomics
Ontologies
- GO: Anatomical entity
Phenotypes
Genetic Variation
- Variant table
- Variant image
- Structural variants
Gene expression
Pathway
Molecular interactions
Regulation
External references
Supporting evidence
ID History
- Gene history

Configure this page

Share this page

Bookmark this page

.

Gene: NCOA2 ENSONIG00000014253

.

Description

nuclear receptor coactivator 2 [Source:ZFIN;Acc:ZDB-GENE-010406-3]

Location

Primary_assembly LG9: 19,855,987-19,893,148 reverse strand.

O_niloticus_UMD_NMBU:CM007490.2

About this gene

This gene has 6 transcripts (splice variants), 211 orthologues and 4 paralogues.

Transcripts

Show transcript tableHide transcript table

Transcript ID	Name	bp	Protein	Translation ID	Biotype	UniProt Match	Flags
ENSONIT00000017933.2	NCOA2-201	4748	1538aa	ENSONIP00000017918.2	Gene/transcipt that contains an open reading frame (ORF).Protein coding	I3K9X3	A single transcript chosen for a gene which is the most conserved, most highly expressed, has the longest coding sequence and is represented in other key resources, such as NCBI and UniProt. This is defined in detail on http://www.ensembl.org/info/genome/genebuild/canonical.htmlEnsembl Canonical,
ENSONIT00000058968.1	NCOA2-202	4599	1498aa	ENSONIP00000062154.1	Gene/transcipt that contains an open reading frame (ORF).Protein coding	A0A669DMV5	-
ENSONIT00000017934.2	NCOA2-203	4536	1477aa	ENSONIP00000017919.2	Gene/transcipt that contains an open reading frame (ORF).Protein coding	I3K9X4	-
ENSONIT00000084809.1	NCOA2-204	4536	1477aa	ENSONIP00000033754.1	Gene/transcipt that contains an open reading frame (ORF).Protein coding	A0A669BGU3	-
ENSONIT00000071196.1	NCOA2-206	4524	1507aa	ENSONIP00000057588.1	Gene/transcipt that contains an open reading frame (ORF).Protein coding	A0A669DAG5	-
ENSONIT00000046443.1	NCOA2-205	4320	1405aa	ENSONIP00000066165.1	Gene/transcipt that contains an open reading frame (ORF).Protein coding	A0A669DZB2	-

.

Summary

.

.